SLI
1.940,44
PKT
+1,52
PKT
+0,08
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.10.12 | Julius Bär buy | Nomura | |
| 10.10.12 | Givaudan equal-weight | Morgan Stanley | |
| 10.10.12 | ams-OSRAM buy | Vontobel Research | |
| 10.10.12 | Givaudan hold | Vontobel Research | |
| 09.10.12 | Nestlé buy | Société Générale Group S.A. (SG) | |
| 09.10.12 | Givaudan reduce | Nomura | |
| 09.10.12 | ABB (Asea Brown Boveri) underperform | Cheuvreux SA | |
| 09.10.12 | Kühne + Nagel International buy | Nomura | |
| 09.10.12 | Julius Bär buy | Sarasin Research | |
| 09.10.12 | Givaudan neutral | Sarasin Research | |
| 09.10.12 | Givaudan hold | Vontobel Research | |
| 09.10.12 | Holcim outperform | Sanford C. Bernstein and Co., Inc. | |
| 08.10.12 | Novartis halten | Independent Research GmbH | |
| 08.10.12 | Swiss Re overweight | J.P. Morgan Cazenove | |
| 08.10.12 | Novartis reduce | Vontobel Research | |
| 08.10.12 | Swatch (I) neutral | J.P. Morgan Cazenove | |
| 05.10.12 | Givaudan neutral | UBS AG | |
| 05.10.12 | Lonza hold | Vontobel Research | |
| 05.10.12 | Swiss Re neutral | Sarasin Research | |
| 05.10.12 | Sonova neutral | Sarasin Research | |
| 05.10.12 | Straumann hold | Vontobel Research | |
| 05.10.12 | Sonova buy | Vontobel Research | |
| 04.10.12 | Novartis buy | Nomura | |
| 04.10.12 | Givaudan overweight | J.P. Morgan Cazenove | |
| 04.10.12 | Givaudan neutral | Credit Suisse Group | |
| 04.10.12 | Nestlé neutral | Citigroup Corp. | |
| 04.10.12 | Swatch (I) buy | Sarasin Research | |
| 04.10.12 | Swiss Re buy | Vontobel Research | |
| 04.10.12 | Swatch (I) buy | Vontobel Research | |
| 03.10.12 | UBS overweight | HSBC | |
| 02.10.12 | Holcim hold | Deutsche Bank AG | |
| 02.10.12 | Swiss Re buy | Société Générale Group S.A. (SG) | |
| 02.10.12 | Nestlé buy | Sarasin Research | |
| 02.10.12 | Richemont buy | Vontobel Research | |
| 01.10.12 | ABB (Asea Brown Boveri) sell | Deutsche Bank AG | |
| 01.10.12 | Holcim underperform | Cheuvreux SA | |
| 01.10.12 | Novartis buy | Sarasin Research | |
| 01.10.12 | Novartis reduce | Vontobel Research | |
| 01.10.12 | ABB (Asea Brown Boveri) outperform | Sanford C. Bernstein and Co., Inc. | |
| 28.09.12 | Nestlé overweight | J.P. Morgan Cazenove |